Methadone Hydrochloride Tablet
FDA Label NDC 0406-5755

57 label sections · Submitted to the FDA by Specgx Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Specgx Llc for the product Methadone Hydrochloride (NDC 0406-5755). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: serious and life-threatening risks from use of methadone hydrochloride tablets, 1 indications and usage, 2.1        conditions for distribution and use of methadone products for the treatment of opioid addiction, 2.2        important general information, 2.3        patient access to an opioid overdose reversal agent for the emergency treatment of opioid overdose, 2.4        methadone hydrochloride tablets for management of pain, 2.5        titration and maintenance of therapy for pain, 2.6        safe reduction or discontinuation of methadone hydrochloride tablets for pain, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.